Long-Term Suppressive Therapeutic-Drug-Monitoring-Guided Dalbavancin Therapy for Cardiovascular Prosthetic Infections

• Main Authors: Altea Gallerani (Author), Milo Gatti (Author), Andrea Bedini (Author), Stefania Casolari (Author), Gabriella Orlando (Author), Cinzia Puzzolante (Author), Erica Franceschini (Author), Marianna Menozzi (Author), Antonella Santoro (Author), Nicole Barp (Author), Sara Volpi (Author), Alessandra Soffritti (Author), Federico Pea (Author), Cristina Mussini (Author), Marianna Meschiari (Author)
• Format: Book
• Published: MDPI AG, 2023-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Dalbavancin represents a promising treatment for cardiovascular prosthetic infections due to its prolonged half-life, bactericidal activity, large spectrum of activity, and excellent biofilm penetration. However, the use of dalbavancin in this setting is limited, and only a few cases have performed...